CA
LLY icon

Capitolis Advisors’s Eli Lilly LLY Stock Holding History

Capitolis Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-49,920
Closed -$13.8M – 332
2021
Q4 		$13.8M Buy
49,920
+10,039
+25% +$2.54M 0.08% 177
2021
Q3 		$9.53M Buy
39,881
+8,077
+25% +$1.99M 0.09% 174
2021
Q2 		$7.3M Sell
31,804
-35,224
-53% -$7.08M 0.09% 193
2021
Q1 		$12.5M Sell
67,028
-12,483
-16% -$2.44M 0.22% 105
2020
Q4 		$13.4M Buy
+79,511
New +$11.9M 0.22% 110

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capitolis Advisors's LLY Position: Q1 2022 in Review

Capitolis Advisors sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 49,920 shares — an estimated $13.8M sold.

Capitolis Advisors first reported a position in LLY in Q4 2020 and held it in 5 quarters. The position peaked at $13.8M in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Capitolis Advisors reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 49,920 Eli Lilly shares in Q1 2022, an estimated $13.8M.
  • Capitolis Advisors first reported a position in Eli Lilly in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's Eli Lilly position peaked at $13.8M in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.